Juan Jesús
Cruz Hernández
Profesor Emérito Honorífico
Publicaciones en las que colabora con Juan Jesús Cruz Hernández (18)
2023
2022
-
Cardiac magnetic resonance to detect different patterns of myocardial injury in patients receiving immune checkpoint inhibitors
Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 266-269
2005
-
Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer
Anti-Cancer Drugs, Vol. 16, Núm. 1, pp. 77-82
2004
2003
-
Biweekly docetaxel and vinorelbine in anthracycline-resistant metastatic breast cancer: A multicenter phase II study
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 26, Núm. 2, pp. 127-131
1997
-
Metastasis en vesicular biliar en un paciente con melanoma
Neoplasia, Vol. 14, Núm. 1, pp. 32-34
-
Quimioterapia y radioterapia secuenciales en el tratamiento del carcinoma de cabeza y cuello localmente avanzado. Resultados a largo plazo
Acta Otorrinolaringologica Espanola, Vol. 48, Núm. 2, pp. 127-132
-
Randomized trial of neoadjuvant chemotherapy with cisplatin plus 5- fluorouracil, with or without leurcovorin, in locally advanced head and neck cancer [1]
Annals of Oncology
1996
-
Do the conventional clinicopathologic parameters predict for response and survival in head and neck cancer patients undergoing neoadjuvant chemotherapy?
Tumori, Vol. 82, Núm. 6, pp. 560-566
-
Mediastinal mass following chemotherapy in patients with Ewing sarcoma and osteosarcoma
Journal of Internal Medicine, Vol. 239, Núm. 5, pp. 457-460
-
Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
The Journal of infusional chemotherapy, Vol. 6, Núm. 4, pp. 217-220
-
QUIMIOTERAPIA NEOADYUVANTE CON CISPLATINO Y 5-FLUOROURACILO CON O SIN ACIDO FOLINICO COMO TRATAMIENTO DEL CARCINOMA DE CABEZA Y CUELLO LOCALMENTE AVANZADO. ESTUDIO EN FASE II
Neoplasia, Vol. 13, Núm. 3, pp. 74-77
1995
-
Four days' continuous infusion of cisplatin-5-fluorouracil and short daily infusion of high-dose leucovorin as induction chemotherapy for locally advanced head and neck cancer.
The Journal of infusional chemotherapy, Vol. 5, Núm. 3, pp. 125-128
-
Suspected extragonadal germ-cell cancer syndrome presenting with an orbital mass and elevation of serum CEA, CA19-9 and CA50 levels
Tumori, Vol. 81, Núm. 5, pp. 378-380
1994
-
Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil, both in continuous 96-hour infusion, in the treatment of locally advanced head and neck cancer
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 17, Núm. 1, pp. 6-9
1993
-
Oat-cell carcinoma of primary location in the pericardium. A case report
Tumori, Vol. 79, Núm. 2, pp. 144-146
1992
-
Phase II study with the combination of mitomycin C, epirubicin and vincristine (MEV) as rescue treatment in previously treated metastatic breast cancer patients
Libri Oncologici, Vol. 21, Núm. 3, pp. 179-182
1989
-
Four‐day continuous infusion of cisplatin and 5‐fluorouracil in head and neck cancer
Cancer, Vol. 63, Núm. 10, pp. 1927-1930